10-Year Outcomes after Monitoring, Surgery, or Radiotherapy for Localized Prostate Cancer - Wikidata - awgldk - TriplyDB

10-Year Outcomes after Monitoring, Surgery, or Radiotherapy for Localized Prostate Cancer

10-Year Outcomes after Monitoring, Surgery, or Radiotherapy for Localized Prostate Cancer

http://www.wikidata.org/entity/Q28005473

about

Data-Based Radiation Oncology: Design of Clinical Trials in the Toxicity Biomarkers Era.Discerning the survival advantage among patients with prostate cancer who undergo radical prostatectomy or radiotherapy: The limitations of cancer registry data.Identification of endonuclease domain-containing 1 as a novel tumor suppressor in prostate cancer.Does early resection of presumed low-grade glioma improve survival? A clinical perspective.Informed consent in randomised controlled trials: development and preliminary evaluation of a measure of Participatory and Informed Consent (PIC).New advances in focal therapy for early stage prostate cancer.Patient-Reported Outcomes after Monitoring, Surgery, or Radiotherapy for Prostate Cancer Prostate Cancer Radiation Therapy: What Do Clinicians Have to Know?The Long-Term Effect of Radical Prostatectomy on Erectile Function, Urinary Continence, and Lower Urinary Tract Symptoms: A Comparison to Age-Matched Healthy Controls.Immune Modulation by Androgen Deprivation and Radiation Therapy: Implications for Prostate Cancer Immunotherapy.Adaptation of the By-Band randomized clinical trial to By-Band-Sleeve to include a new intervention and maintain relevance of the study to practice.Improved Recovery of Erectile Function in Younger Men after Radical Prostatectomy: Does it Justify Immediate Surgery in Low-risk Patients?Intermediate-term outcome after PSMA-PET guided high-dose radiotherapy of recurrent high-risk prostate cancer patients.Active Surveillance for Intermediate Risk Prostate Cancer.Metastasis-Free Survival Is a Strong Surrogate of Overall Survival in Localized Prostate Cancer.Hypo-fractionated SBRT for localized prostate cancer: a German bi-center single treatment group feasibility trial.The phytological future of prostate cancer staging: PSMA-PET and the dandelion theory.Role of mpMRI of the prostate in screening for prostate cancer.Surgical Techniques to Optimize Early Urinary Continence Recovery Post Robot Assisted Radical Prostatectomy for Prostate Cancer.Adverse Pathologic Findings for Men Electing Immediate Radical Prostatectomy: Defining a Favorable Intermediate-Risk Group.Erectile Function after Stereotactic Body Radiotherapy for Localized Prostate Cancer.Diagnosis, staging, and risk stratification in prostate cancer: Utilizing diagnostic tools to avoid unnecessary therapies and side effects.Contemporary management of men with high-risk localized prostate cancer in the United States.Toxicity after post-prostatectomy image-guided intensity-modulated radiotherapy using Australian guidelines.High-dose-rate brachytherapy as salvage modality for locally recurrent prostate cancer after definitive radiotherapy : A systematic review.Potential overtreatment among men aged 80 years and older with localized prostate cancer in Japan.Therapeutic Ultrasound and Prostate Cancer.Treatment Decision Regret Among Long-Term Survivors of Localized Prostate Cancer: Results From the Prostate Cancer Outcomes Study.Comparative effectiveness of prostate cancer treatments for patient-centered outcomes: A systematic review and meta-analysis (PRISMA Compliant)Pre- and post-prostatectomy variables associated with pelvic post-operative radiotherapy in prostate cancer patients: a national registry-based study.Association Between Radiation Therapy, Surgery, or Observation for Localized Prostate Cancer and Patient-Reported Outcomes After 3 Years.Clinical and molecular rationale to retain the cancer descriptor for Gleason score 6 disease.PRECISION MANAGEMENT OF LOCALIZED PROSTATE CANCER.Management of Urethral Stricture and Bladder Neck Contracture Following Primary and Salvage Treatment of Prostate Cancer.GATA3 expression in benign prostate glands with radiation atypia: a diagnostic pitfall.Magnetic resonance imaging targeted transperineal prostate biopsy: a local anaesthetic approach.Androgen deprivation therapy for prostate cancer and dementia risk: a systematic review and meta-analysis.Extracellular vesicles for liquid biopsy in prostate cancer: where are we and where are we headed?Reassurance for patients with non-specific conditions - a user's guide.The Contemporary Role of Multiparametric Magnetic Resonance Imaging in Active Surveillance for Prostate Cancer.

P2860

Q30234489-C26ED282-0C6D-4E18-B9ED-36867D14541F Q31155248-6B4DD2EF-8765-4C4B-844F-4140A2D64033 Q33716836-081A180B-056B-4DA6-B8F6-D63BC2112E5D Q33867304-1D4765A2-DF50-42CC-852D-78A06D33C01A Q33909403-9DDE7F1E-6187-4ACE-B6B4-332DDF6352C5 Q36411076-DFB93FFE-952D-4A38-90EF-E954F34071C9 Q37468498-AF75E421-0943-4FAF-93E1-874BD7F6F941 Q37578562-7092075B-E937-4A19-B057-441B03DF8514 Q37651433-74A6D0F2-D5E7-42C6-A863-4CA0FE1C1182 Q37676065-9DA41DDE-0D64-482C-B9D8-0C4A95FF571A Q38369795-D16EDB3D-41E6-465F-97C6-7E15CD848953 Q38603257-E3AF852D-2DAE-4007-983A-D6FEE9667863 Q38613594-19798A4B-7C25-4AC7-8FCC-973E6CE0DB66 Q38627996-4CFC1D40-86B0-4B0E-9133-5ED984BFF407 Q38630553-68AF1287-AA8B-4D4F-84B6-5DFEE27CE9F0 Q38640272-86A11A61-CC3B-4D7B-B60C-72DA278CA8FA Q38648799-42A8A15C-C00E-4F09-B236-F5B3C6CFEA31 Q38671170-22D6BA16-C9ED-4F14-884F-6D2314C8FD15 Q38674415-2BF41539-D209-4A64-B6C4-8C816ED58364 Q38675548-A7D25D8F-8D3B-42A4-9743-E50268C35A24 Q38677828-9256F874-06BA-4A04-B8E3-B426F31B931E Q38687398-04F8E974-FDD5-4101-AC4A-4F52B730A203 Q38717765-719079CA-3DAB-45B4-97C3-6C2AC5EBEB89 Q38721392-6009EDDE-27DE-4D2B-908B-950A75BA2433 Q38721676-030255E0-A2A3-46D1-9D45-4934857ADD72 Q38736557-F4B2CB4A-40CB-45EF-B3DC-1380EB136BB7 Q38745164-ED1838CE-B316-43CD-BE86-80BD53E67695 Q38792110-98348C23-4681-4C7F-AD55-365A8D25649F Q38804659-D57932EE-094E-4C3F-A100-3435706AF508 Q38830669-D1921856-3178-4B6C-AF3C-85D36FCDF9E6 Q38890085-B3AEA852-8608-410B-9E41-28BCF6D98CF8 Q39023426-9AFF0CF1-E52B-4ECE-8F10-75E7000113BF Q39108592-ECD597D4-D243-43B1-B925-88B117A8EA3D Q39151903-D2B1215F-8296-473A-B969-2841866A89BC Q39186240-709678E7-B00F-40D4-87CE-BCCA1CCA9CF0 Q39191190-F7EAE63B-B5A1-4FE6-A1B2-419E14B56D5C Q39204570-46C25A8C-FE8B-4A21-816F-0CC11955E964 Q39218490-036F9BAA-2D64-4296-B6DA-1CE2670A6683 Q39261981-45F6BA4E-A993-41AC-9293-A2A682B4AFE1 Q39356191-EB494667-6CD8-4180-9D24-E0C46822AC1A

P2860

10-Year Outcomes after Monitoring, Surgery, or Radiotherapy for Localized Prostate Cancer

http://www.wikidata.org/entity/Q28005473

description

2016 nî lūn-bûn

@nan

2016 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2016 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

name

10-Year Outcomes after Monitoring, Surgery, or Radiotherapy for Localized Prostate Cancer

@ast

10-Year Outcomes after Monitoring, Surgery, or Radiotherapy for Localized Prostate Cancer

@en

10-Year Outcomes after Monitoring, Surgery, or Radiotherapy for Localized Prostate Cancer

@nl

type

label

10-Year Outcomes after Monitoring, Surgery, or Radiotherapy for Localized Prostate Cancer

@ast

10-Year Outcomes after Monitoring, Surgery, or Radiotherapy for Localized Prostate Cancer

@en

10-Year Outcomes after Monitoring, Surgery, or Radiotherapy for Localized Prostate Cancer

@nl

prefLabel

10-Year Outcomes after Monitoring, Surgery, or Radiotherapy for Localized Prostate Cancer

@ast

10-Year Outcomes after Monitoring, Surgery, or Radiotherapy for Localized Prostate Cancer

@en

10-Year Outcomes after Monitoring, Surgery, or Radiotherapy for Localized Prostate Cancer

@nl

P1433

Q28005473-E8B16988-10C1-4A47-BCBC-14E72A848698

P1476

Q28005473-79B4109F-96EC-42AE-987C-0D25E369F3CB

P2093

Q28005473-003C2E47-9F02-40F1-81A8-8BBBA41D7FBC

Q28005473-11FD63CF-EA41-4813-A584-E1F9E4E543BE

Q28005473-1B7EB954-377C-42F7-91B0-81E60B566691

Q28005473-1E9D83F2-97C0-4D1D-AE0B-E71F664A55F3

Q28005473-20A38D10-C06F-4CBB-966E-9E73C4569C9F

Q28005473-25B59903-41C0-4B94-A5CA-24CFFF1B6F6C

Q28005473-2CBBE016-2F2B-4721-95AF-C52AB3AE3A9D

Q28005473-42D68633-DF59-4365-91FC-E7C4C04E8857

Q28005473-48E9586F-A439-45C6-9C84-3ADA158B8AA9

Q28005473-5852DF2F-C587-481E-8E53-353B4DD186A0

P304

Q28005473-71330D04-CC11-4C4F-9183-8406FE0FDAC4

P31

Q28005473-A6E81212-EB2A-4826-92D3-E75C08D2807C

P356

Q28005473-1D8E44AF-BE75-45D8-B6BA-24C35B09D0DE

P407

Q28005473-43EA1EBD-96E8-4F31-873F-E571B7D2FF2B

P433

Q28005473-0AAECD7F-DC0D-4AF1-92D8-CD2E49F7EDD8

P478

Q28005473-A3E87CD1-D330-427F-AC5A-10DA0D866588

P50

Q28005473-4209F40F-9F01-44DC-8B65-BE8EFF2D04E0

Q28005473-8BA7BB4F-328B-4F6F-A95C-32B61013F63C

Q28005473-BB95EB0D-B325-4C34-9E00-46D723F3DFD0

Q28005473-BEA916C3-9918-4945-BA97-381B3139E951

P577

Q28005473-AB695511-3944-434A-8058-68D26E34E6FD

P698

Q28005473-0A1FC8F3-3137-4B6E-9882-FEF4EEA246BC

P921

Q28005473-6BDF7220-A46A-4534-8B8D-DA4BEC6A52F9

P356

P1433

The New England Journal of Medicine

P1476

10-Year Outcomes after Monitoring, Surgery, or Radiotherapy for Localized Prostate Cancer

@en

P2093

Alan Doherty

http://www.w3.org/2001/XMLSchema#string

Alan Paul

http://www.w3.org/2001/XMLSchema#string

Andrew Doble

http://www.w3.org/2001/XMLSchema#string

David E Neal

http://www.w3.org/2001/XMLSchema#string

David Gillatt

http://www.w3.org/2001/XMLSchema#string

Derek J Rosario

http://www.w3.org/2001/XMLSchema#string

Edward Rowe

http://www.w3.org/2001/XMLSchema#string

Eleanor Walsh

http://www.w3.org/2001/XMLSchema#string

Freddie C Hamdy

http://www.w3.org/2001/XMLSchema#string

Howard Kynaston

http://www.w3.org/2001/XMLSchema#string

P304

1415-1424

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1056/NEJMOA1606220

http://www.w3.org/2001/XMLSchema#string

P407

P433

15

http://www.w3.org/2001/XMLSchema#string

P478

375

http://www.w3.org/2001/XMLSchema#string

P50

P577

2016-09-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27626136

http://www.w3.org/2001/XMLSchema#string

P921

radiation therapy